Ironwood Pharmaceuticals Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.22

+0.05 (+1.20%)

As of May 9, 9:40 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +1,125.1% upside

Low Target $40.79

Average Target $51.70

High Target $62.56

Current Price $4.22

Current
$4.22

Target
$51.70

$40.79 $51.70 avg $62.56

Scenario Analysis

Bear Case

$40.79

866.6%

Low target

Base Case

$51.70

+1,125.1%

Avg target

Bull Case

$62.56

+1,382.5%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$5.78

-27.0% from high

52-Week Low

$0.53

+700.6% from low

Target vs 52W High

$51.70

+794.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%